John Jeffrey McAtee

Title: John Jeffrey McAtee: Innovator in Pharmaceutical Development

Introduction

John Jeffrey McAtee is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of TRPV4 antagonists. With a total of 4 patents to his name, McAtee's work has had a considerable impact on medical research and drug development.

Latest Patents

Among his latest patents, McAtee has focused on TRPV4 antagonists. His inventions relate to pyrrolidine sulfonamide analogs, which are pharmaceutical compositions that have shown promise in their use as TRPV4 antagonists. This innovative approach has the potential to lead to new treatments in various medical conditions.

Career Highlights

Throughout his career, McAtee has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

McAtee has collaborated with several professionals in his field, including Edward J. Brnardic and Carl A. Brooks. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John Jeffrey McAtee is a distinguished inventor whose work in pharmaceutical development, particularly in TRPV4 antagonists, has made a lasting impact. His contributions continue to influence the field and pave the way for future innovations.